These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mupirocin prophylaxis misses by a nose. Chambers HF; Winston LG Ann Intern Med; 2004 Mar; 140(6):484-5. PubMed ID: 15023716 [No Abstract] [Full Text] [Related]
9. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections? Wertheim HF; Vos MC Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Laupland KB; Conly JM Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405 [TBL] [Abstract][Full Text] [Related]
11. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397 [TBL] [Abstract][Full Text] [Related]
12. [Mupirocin: prophylaxis of hospital-acquired infections due to Staphylococcus aureus and sanitation of hospital environment]. Mitrokhin SD Antibiot Khimioter; 2003; 48(9):13-9. PubMed ID: 15002175 [TBL] [Abstract][Full Text] [Related]
13. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105 [TBL] [Abstract][Full Text] [Related]
14. [How promising is decontamination treatment of MRSA carriers?]. Panknin HT Med Monatsschr Pharm; 2007 Mar; 30(3):114-5. PubMed ID: 17405489 [No Abstract] [Full Text] [Related]
15. Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis. Young LS; Winston LG Infect Control Hosp Epidemiol; 2006 Dec; 27(12):1304-12. PubMed ID: 17152027 [TBL] [Abstract][Full Text] [Related]
16. Increasing mupirocin resistance of Staphylococcus aureus in CAPD--should it continue to be used as prophylaxis? Conly JM; Vas S Perit Dial Int; 2002; 22(6):649-52. PubMed ID: 12556065 [TBL] [Abstract][Full Text] [Related]
17. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636 [TBL] [Abstract][Full Text] [Related]
18. New approaches to prevention of staphylococcal infection in surgery. van Rijen MM; Kluytmans JA Curr Opin Infect Dis; 2008 Aug; 21(4):380-4. PubMed ID: 18594290 [TBL] [Abstract][Full Text] [Related]
19. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin]. Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130 [TBL] [Abstract][Full Text] [Related]
20. [Mupirocin: its use]. Janin N; Mignon A Ann Dermatol Venereol; 2000 May; 127(5):517-8. PubMed ID: 10863186 [No Abstract] [Full Text] [Related] [Next] [New Search]